ST2 Biomarker Risk Tier Calculator
Enter biomarker result
Enter the measured soluble ST2 concentration in ng/mL to view its category and clinical context.
About soluble ST2
Soluble ST2 (sST2) is a member of the interleukin-1 receptor family and is studied as a biomarker associated with myocardial stress, remodeling, and prognosis in heart failure. It may add prognostic information alongside clinical assessment and natriuretic peptides.
The original calculator used three bands: below 35, 35–70, and above 70 ng/mL. These bands are retained for continuity, but they should be treated as a simplified categorization rather than a universally validated risk score.
Thresholds used in this calculator
| sST2 concentration | Category shown | Important limitation |
|---|---|---|
| <35 ng/mL | Lower | Does not exclude heart failure or adverse outcomes. |
| 35–70 ng/mL | Intermediate | Interpretation depends on clinical setting and assay. |
| >70 ng/mL | Higher | Proposed in selected acute-HF approaches; not a universal treatment threshold. |
Clinical use
- Interpret alongside symptoms, examination, imaging, natriuretic peptides, and other relevant data.
- Thresholds may perform differently in acute versus chronic heart failure.
- Do not use this simplified category alone to diagnose heart failure, determine disposition, or change treatment.
References
Journal of the American College of Cardiology. 2007.
doi:10.1016/j.jacc.2007.05.014Journal of the American College of Cardiology. 2008;52:1458–1465.
doi:10.1016/j.jacc.2008.07.042JACC. 2019. Discusses the limitations of applying a single sST2 cutoff across acute and chronic HF settings.
JACC articleJournal of the American College of Cardiology. 2017;70:2389–2392.
doi:10.1016/j.jacc.2017.09.031Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.